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Abstract
Background: Bardet Biedl Syndrome (BBS) is a rare condition of multi-organ dysfunction with characteristic clinical
features of retinal degeneration, truncal obesity, postaxial polydactyly, genital anomaly, intellectual disability and
renal dysfunction. It is a hetero-genetic disorder and nineteen BBS genes have been discovered so far.
Methods: Whole genome SNP genotyping was performed by using CytoScan® 750 K array (Affymetrix). Subsequently,
the segregation of the disease locus in the whole family was carried out by genotyping STS markers within
the homozygous interval. Finally, the mutation analysis was performed by Sanger DNA sequencing.
Results: In the present molecular study a consanguineous Pakistani family, with autosomal recessive BBS, was
analyzed. The clinical analysis of affected individuals presented with synpolydactyly, obesity, intellectual disability, renal
abnormality and retinitis pigmentosa. The presented phenotype was consistent with the major features of BBS
syndrome. Homozygosity mapping identified a common homozygous interval within the known BBS9 locus.
Sequence analysis of BBS9/PTHB1 gene revealed a single base deletion of c.299delC (p.Ser100Leufs*24) in exon 4. This
frame-shift mutation presumably leads to a 122 amino acid truncated protein with complete loss of its C-terminal
PTHB1 domain in combination with a partial loss of the N-terminal PTHB1 domain as well. BBS9/PTHB1 gene mutations
have been shown to be associated with BBS syndrome and to the best of our knowledge this study reports the first
Pakistani family linked to the BBS9 gene.
Conclusion: Our molecular findings expand the mutational spectrum of BBS9 gene and also explain the genetic
heterogeneity of Pakistan families with BBS syndrome. The growing number of mutations in BBS genes in combination
with a detailed phenotypical description of patients will be helpful for genotype-phenotype correlation, targeted
genetic diagnosis, prenatal screening and carrier testing of familial and non-familial BBS patients.
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Background
Bardet Beidl syndrome (BBS) is a multi-symptomatic
ciliopathy. The major clinical manifestations of this dis-
order are cone-rod dystrophy, truncal obesity, postaxial
polydactyly, genital anomaly, learning disability and renal
dysfunction [1]. Clinically BBS is a heterogeneous dis-
order with variable inter- and intra-familial features [2],
therefore its diagnosis is established by the presence of
four or three of the major features and two minor fea-
tures like speech delay, brachydactyly/syndactyly, cardio-
vascular anomalies etc. [3, 4]. The incidence rate of BBS
varies among the different ethnicities, and occur with
the ratio of 1: 156,000 in Tunisia [5], 1: 140,000–160,000
in North America to Europe, 1: 17,000 in Kuwait, and 1:
18,000 in Newfoundland [6, 7].
Genetically BBS is segregated in an autosomal reces-
sive fashion with high degree of locus and allele hetero-
geneity. The combinatorial approach of SNP microarray
(for homozygosity mapping) with targeted exome se-
quencing (for mutation analysis) has speed-up the dis-
covery of causative gene and its underlying pathogenic
mutation [8, 9]. Genetic analysis of BBS patients have
identified nineteen disease responsible genes (BBS1-19),
most of which encode BBSome protein (BBS1, BBS2,
BBS4, BBS5, BBS7, BBS8/TTC8, BBS9/PTHB1, BBS17/
LZTFL1 and BBS18/BBIP1) while some produce basal
body interacting protein (BSS13/MKS1, BBS14/EP290/
NPHP6, BBS15/WDPCP and BBS16/SDCCAG8), chap-
eronin complex protein (MKKS, BBS10 and BBS12), E3
ubiquitin ligase (BBS11/TRIM32), and a GTPase protein
complex (BBS3/ARL6 and BBS19/IFT27) [10, 11].
Physiologically BBSome is of prime importance in cilio-
genesis due to its functional role in membrane traffick-
ing in primary cilium [12]. The mutational spectrum of
BBS genes is variable among different populations. A
high proportion of European and Caucasian families are
reported to have mutation in BBS1 and BBS10 gene with
the ratio of 23.2 % and 20 % respectively [13, 14], while
in the Arab population most of the mutations are found
in BBS1, BBS2, BBS3, BBS4 and BBS8 [10, 15–17] with a
total prevalence rate of 67 %. Although no prevalence
data of the BBS genes have been estimated yet in the
Pakistani population however most of the mutations
occur in BBS1 [18], BBS3/ARL6 [19], BBS10 [19, 20],
and BBS12 [21].
In the present linkage study, we have ascertained a
Saraiki origin BBS family from the Kirikhaisor village of
D.I.Khan in the KPK province of Pakistan. It was a con-
sanguineous family with two affected siblings presenting
with BBS features. Homozygosity mapping in combin-
ation with Sanger sequencing of a candidate gene identi-
fied a novel single base deletion mutation in BBS9 gene
[(c.299delC) & (p.Ser100Leufs*24)]. This frame shift mu-
tation presumably leads to truncated nonfunctional
protein. These data present the first report of the BBS9
gene mutation in a Pakistani family and thus increase
the mutational spectrum of Bardet Beidl syndrome in
this ethnic region.
Methods
From sampling to DNA isolation
The consanguineous family for the present molecular in-
vestigation was ascertained from the rural area of D.I.Khan
in the Khyber-Pakhtoonkhwa Province of Pakistan. The
study was approved by the ethical review board of Gomal
Centre of Biochemistry and Biotechnology, Gomal Univer-
sity D.I.Khan, Pakistan. Moreover, informed written con-
sent was obtained from all individuals participating in the
study. The family was visited at its residence and blood
samples were collected. The patients were examined in de-
tail for all apparent phenotypic features to document the
major as well as the minor BBS symptoms. The parents
were also counseled in detail on prenatal, perinatal, and
neonatal medical problems. Subsiquently, the DNA was
isolated from the peripheral blood sample by using stand-
ard Phenol-Chloroform method.
From genome to gene analysis
To investigate the underlying disease gene mutation,
genome-wide SNP genotyping was performed by using
Affymetrix CytoScan 750 K SNP microarray. The SNP
data were analyzed using the Chromosome Analysis
Suite (ChAS) version 1.2 (Affymetrix) to identify the
homozygous by descend region (HBD). The perfect
segregation of identified disease associated HBD re-
gion in the complete family was determined by geno-
typing STR markers D7S493 (36.08 cM), D7S516
(42.93 cM), D7S484 (53.73 cM), and D7S510 (59.8
cM) {Rutgers map B37 [22]} within the homozygous
region. For statistical significance of linkage, two
point and multi point LOD scores were calculated by
using Superlink and GeneHunter software packages
plugged-in the EasyLinkage plus v5.02 software. The
analysis was performed assuming a disease allele fre-
quency of 0.001 with full penetrance at zero recom-
bination fraction [23].
The primers for protein coding exons of BBS9 gene
were designed using the online version of Primer 3 plus
software (version 0.4.0) [24]. The sequence reactions
were performed with BigDye Terminator v3.1 cycle se-
quencing kit (Applied Biosystem, USA) and the sequen-
cing products were analyzed by the Genetic analyzer
3130xl (Life Technologies, USA). The sequence data
were then aligned with the BBS9 reference sequence via
blast like alignment tool (BLAT) tool package of UCSC
Genome Browser [25].
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Results
In this study, four individuals from a multi-generation
family were enrolled for molecular investigation of an
underlying disease gene mutation. The recruited individ-
uals consist of both affected siblings (IV-4 and IV-5),
one unaffected brother (IV-6) and an asymptomatic car-
rier mother (III-2). Pedigree analysis revealed an auto-
somal recessive mode of disease segregation (see Fig. 1).
Clinical findings
The clinical examination of both BBS patients dem-
onstrated bilateral postaxial synpolydactyly of hands
and feet, mild progressive retinal degeneration, intel-
lectual disability, renal dysfunction, and obesity as a
major BBS features, while mild hearing loss was also
noticed as a minor feature in both affected individ-
uals. The pattern of postaxial synpolydactyly in the
female showed hepta-dactyly of left hand and foot but
the right hand and foot had six digits, while the af-
fected male had only hepta-dactyly of the right hand.
The detailed clinical description of both affected indi-
viduals is shown in Table 1.
Genetic findings
Whole genome SNP genotyping and linkage analysis
Genome-wide homozygosity mapping revealed a 18.45
Mb (HG19: chr7: 21,596,876-39,320,676) long HBD re-
gion between markers rs56356943 to rs12112084, on the
short arm of chromosome 7. Segregation mapping by
STR markers in the complete family, through STR
markers, confirmed the inheritance of the homozygous
region with disease etiology. Linkage analysis generated
a suggestive two point and multipoint LOD scores of
0.92 and 1.26 respectively at same marker D7S484
(53.73 cM) with zero recombination fraction. The identi-
fied homozygous interval harbored the BBS9 gene which
is reported to be associated with BBS.
Sequence analysis of the BBS9 gene
Sanger DNA sequencing of the BBS9 gene revealed a
homozygous deletion of cytosine nucleotide in exon 4
(c.299delC). At protein level the reported deletion is pre-
dicted to result in a frame-shift mutation p.Ser100-
Leufs*24 (UniProtKB accession: Q3SYG4). The predicted
premature stop codon presumably disrupts the open
reading frame and results in a truncated polypeptide
Fig. 1 Family pedigree and facial photographs of patient IV-4 and IV-5. Symbols, tagged with asterisks, indicate individuals selected for genetic
analysis in addition to both affected persons
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of 122 amino acids with complete loss of C-terminal
PTHB1 domain (see Fig. 2). The identified sequence
variant is not present in exome variant server (URL:
http://exac.broadinstitute.org/), exome aggregation con-
sortium (URL: http://evs.gs.washington.edu/EVS/), The
Singapore Human Mutation and Polymorphism database
(URL: http://shmpd.bii.a-star.edu.sg/) the Indian Genetic
Disease database (URL: http://www.igdd.iicb.res.in/IGDD/
home.aspx) and 100 normal controls from Pakistan
(n = 50) and Arab population (n = 50).
Discussion
Ciliopathies are a distinct group of genetic disorders
which are caused by primary ciliary dysfunction with
pleiotropic effect. Bardet Biedl syndrome is a rare auto-
somal recessive ciliopathic disorder characterized by
retinal degeneration, intellectual disability, obesity, renal
complications and polydactyly as predominant pheno-
types. It is a heterogenetic disorder with 19 causative
genes, whose protein products together constitute centro-
some and/or basal body which is physiologically involved
in ciliary function [26, 27]. Here in this report, we discov-
ered a novel single base deletion in the 4th exon of BBS9
gene (c.299delC), which presumably leads to truncated
protein with complete loss of the C terminal PTHB1 do-
main (UniProtKB accession:Q3SYG4). The presence of
the premature stop codon will likely lead to degradation
of the resulting mRNA through Nonsense-mediated
mRNA Decay.
BBS9 protein is the component of BBSome protein
complex, a central entity of ciliogenesis, which is local-
ized in the primary cilia and peri-centriolar region. Ten
BBSome subunits (from BBS1 to 10) have been discov-
ered, and BBS9 has a possible role in associating other
subunits [12]. STRING protein interaction database
(URL: www.string-db.org) predicted strong interaction of
BBS9 with BBS5 protein, which suggests that BBS5
could be involved in the assembly of BBSome subunits
through BBS9 interaction. Hence, loss of function muta-
tion in BBS9 may affect the integrity of BBSome proteins
complex due to a structural abnormality in cilia. This
structural aberration could be the reason for disassembly
of BBSome subunits due to defective BBS9-BBS5 pro-
tein interaction which might be required for proper
organization. The knockdown studies in zebrafish and
mouse have clearly demonstrated the significant role
of BBS9 in cilia biogenesis [28]. Although extensive
work has been performed for the genetic screening of
BBS genes, but the actual function of most BBS pro-
teins are yet to be discovered.
The mutational spectrum of BBS9 gene has re-
ported 12 missense/non-sense mutations, 2 splice site
changes, 2 small deletions, 2 small insertions and 4
gross deletions in BBS phenotype (HGMD database;
URL: http://www.hgmd.cf.ac.uk/ac/index.php), where as
one complex rearrangement in BBS9 is associated
with Wilms tumor (HGMD database; [29]). The clinical
spectrum of both patients reported in this study is
consistent with previous reports, except for a few
novel phenotypic variations. These clinical variations in-
cluded digestion problems (constipation) in both affected
(IV-4 & IV-5), irregular menstrual cycle (IV-5), strabismus
(IV-4), and synpolydactyly of internal digits (IV-4 & IV-5).
The molecular genetics testing of any inherited dis-
order either involves multi-gene panel or the most im-
plicated genes. In case of BBS, the high cost of multi-
gene panels (BBS1- BBS19) and weakly established
genotype-phenotype correlations favor the screening of
highly prevalent BBS1 and BBS10 genes. Hence, keeping
in view the genetic counseling of BBS patients, the large







Age 20 Years 18 Years
Height 5 feet 2 inch 4 feet 10 inch
Weight 75 Kg 65 Kg
BMIa 30.2 (Obese) 30.9 (Obese)
Major BBS phenotypes
Retinal degeneration Yes Yes
Polydactyly Yes Yes
Obesity Yes Yes
Developmental delay Yes Yes
Hypogonadism No No
Renal abnormality Yes Yes
Minor BBS phenotypes




Brachydactyly, syndactyly Yes Yes
Diabetes mellitus No No
Ataxia, imbalance No No
Mild spasticity No No
Dental anomaly No No
Heart problems No No
Liver disorders No
Hearing Loss No Yes
Gastro-intestinal complications Digestion problem Digestion problem
Dermatologic issues No No
Menstruation in female - Irregular
a“BMI calculator” available on CDC (website www.cdc.gov) is used for
BMI calculation
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number of reported BBS genes and unclear phenotypic
association data, genetic screening of the most impli-
cated BBS1 and BBS10 is considered as cost effective.
Nevertheless, prevalences of supposedly rare BBS genes
such as BBS9 might vary in different ethicities and there-
fore prioritization of genes have to be adapted accord-
ingly in a diagnostic setup.
In summary, our data represent the first BBS9 gene
mutation being reported in a Pakistani family associated
with Bardet Biedl syndrome. In addition to cardinal fea-
tures of BBS, slight clinical variations were also observed
in Pakistani siblings. It is assumed that the current study
will contribute to the elucidation of the genetic hetero-
geneity of BBS patients and that the screening of add-
itional BBS cases in future might detect the mutational
hotspot and thus would be helpful in designing a multi-
gene panel for routine diagnosis.
Conclusion
Here in this study we report the first Pakistani family
segregating a novel deletion mutation in BBS9 gene
(c.299delC). The mutation shifts the reading frame and
presumably results in a truncated protein with loss of
functional PTHB1 domains (p.Ser100Leufs*24). The
current finding has increased the mutational spectrum
of the Bardet Biedl Syndrome mutation in the Pakistani
population and thereby will increase our knowledge to
understand the potential role of the BBS9 protein in
BBSome protein complex.
Abbreviation
BBS: Bardet Biedl syndrome; D.I.Khan: Dera Ismail Khan; KPK: Khyber-
Pakhtoonkhwa; DNA: Deoxy ribonucleic acid; SNP: Single nucleotide
polymorphism; ChAS: Chromosome analysis suite; HBD: Homozygous by
Descend; cM: Centi Morgan; LOD: Logarithm of odd; BLAT: Blast like
alignment tool; Mb: Mega base; STR: Short tandem repeat; Ser: Serine;
Leu: Leucine; fs: Frame shift; HGMD: Human gene mutation database.
A B
C
Fig. 2 a- Autozygosity image, showing the common homozygous interval on 7p14.3 that harbors the known BBS9 gene and the defect was
detected in its exon 4. b- Sequence chromatogram of BBS9 exon 4 is showing a homozygous deletion of cytosine in an affected individual
(IV-4), heterozygous mutation in a carrier (III-2) and wild-type sequence in an normal individual (IV-6). c- The protein truncating mutation is
depicting a loss of complete PTHB1 C-terminus domain along with some part of N-terminus, leaving behind a 122 amino acid truncated protein
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